NCT02568150View on ClinicalTrials.gov

Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Moderate-severe Glabellar Lines
Interventions
BIOLOGICAL

Single group, open-label

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT02568150 - Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines | Biotech Hunter | Biotech Hunter